Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))

Christopher G. Willett; Yves Boucher; Emmanuelle Di Tomaso; Dan G. Duda; Lance L. Munn; Ricky T. Tong; Daniel C. Chung; Dushyant V. Sahani; Sanjeeva P. Kalva; Sergey V. Kozin; Mari Mino; Kenneth S. Cohen; David T. Scadden; Alan C. Hartford; Alan J. Fischman; Jeffrey W. Clark; David P. Ryan; Andrew X. Zhu; Lawrence S. Blaszkowsky; Helen X. Chen; Paul C. Shellito; Gregory Y. Lauwers; Rakesh K. Jain

doi:10.1038/nm0604-649c

Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))

Christopher G. Willett, Yves Boucher, Emmanuelle Di Tomaso, Dan G. Duda, Lance L. Munn, Ricky T. Tong, Daniel C. Chung, Dushyant V. Sahani, Sanjeeva P. Kalva, Sergey V. Kozin, Mari Mino, Kenneth S. Cohen, David T. Scadden, Alan C. Hartford, Alan J. Fischman, Jeffrey W. Clark, David P. Ryan, Andrew X. Zhu, Lawrence S. Blaszkowsky, Helen X. ChenPaul C. Shellito, Gregory Y. Lauwers, Rakesh K. Jain

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Original language	English (US)
Number of pages	1
Journal	Nature medicine
Volume	10
Issue number	6
DOIs	https://doi.org/10.1038/nm0604-649c
State	Published - Jun 2004

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1038/nm0604-649c

Cite this

Willett, C. G., Boucher, Y., Di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., Mino, M., Cohen, K. S., Scadden, D. T., Hartford, A. C., Fischman, A. J., Clark, J. W., Ryan, D. P., Zhu, A. X., Blaszkowsky, L. S., ... Jain, R. K. (2004). Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147)). Nature medicine, 10(6). https://doi.org/10.1038/nm0604-649c

Erratum : Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147)). / Willett, Christopher G.; Boucher, Yves; Di Tomaso, Emmanuelle; Duda, Dan G.; Munn, Lance L.; Tong, Ricky T.; Chung, Daniel C.; Sahani, Dushyant V.; Kalva, Sanjeeva P.; Kozin, Sergey V.; Mino, Mari; Cohen, Kenneth S.; Scadden, David T.; Hartford, Alan C.; Fischman, Alan J.; Clark, Jeffrey W.; Ryan, David P.; Zhu, Andrew X.; Blaszkowsky, Lawrence S.; Chen, Helen X.; Shellito, Paul C.; Lauwers, Gregory Y.; Jain, Rakesh K.

In: Nature medicine, Vol. 10, No. 6, 06.2004.

Research output: Contribution to journal › Comment/debate

Willett, CG, Boucher, Y, Di Tomaso, E, Duda, DG, Munn, LL, Tong, RT, Chung, DC, Sahani, DV, Kalva, SP, Kozin, SV, Mino, M, Cohen, KS, Scadden, DT, Hartford, AC, Fischman, AJ, Clark, JW, Ryan, DP, Zhu, AX, Blaszkowsky, LS, Chen, HX, Shellito, PC, Lauwers, GY & Jain, RK 2004, 'Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))', Nature medicine, vol. 10, no. 6. https://doi.org/10.1038/nm0604-649c

Willett, Christopher G. ; Boucher, Yves ; Di Tomaso, Emmanuelle ; Duda, Dan G. ; Munn, Lance L. ; Tong, Ricky T. ; Chung, Daniel C. ; Sahani, Dushyant V. ; Kalva, Sanjeeva P. ; Kozin, Sergey V. ; Mino, Mari ; Cohen, Kenneth S. ; Scadden, David T. ; Hartford, Alan C. ; Fischman, Alan J. ; Clark, Jeffrey W. ; Ryan, David P. ; Zhu, Andrew X. ; Blaszkowsky, Lawrence S. ; Chen, Helen X. ; Shellito, Paul C. ; Lauwers, Gregory Y. ; Jain, Rakesh K. / Erratum : Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147)). In: Nature medicine. 2004 ; Vol. 10, No. 6.

@article{7fd03e9f22ed4d7a945a16146466261f,

title = "Erratum: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))",

author = "Willett, {Christopher G.} and Yves Boucher and {Di Tomaso}, Emmanuelle and Duda, {Dan G.} and Munn, {Lance L.} and Tong, {Ricky T.} and Chung, {Daniel C.} and Sahani, {Dushyant V.} and Kalva, {Sanjeeva P.} and Kozin, {Sergey V.} and Mari Mino and Cohen, {Kenneth S.} and Scadden, {David T.} and Hartford, {Alan C.} and Fischman, {Alan J.} and Clark, {Jeffrey W.} and Ryan, {David P.} and Zhu, {Andrew X.} and Blaszkowsky, {Lawrence S.} and Chen, {Helen X.} and Shellito, {Paul C.} and Lauwers, {Gregory Y.} and Jain, {Rakesh K.}",

year = "2004",

month = jun,

doi = "10.1038/nm0604-649c",

language = "English (US)",

volume = "10",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Erratum

T2 - Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer (Nature Medicine (2004) 10 (145-147))

AU - Willett, Christopher G.

AU - Boucher, Yves

AU - Di Tomaso, Emmanuelle

AU - Duda, Dan G.

AU - Munn, Lance L.

AU - Tong, Ricky T.

AU - Chung, Daniel C.

AU - Sahani, Dushyant V.

AU - Kalva, Sanjeeva P.

AU - Kozin, Sergey V.

AU - Mino, Mari

AU - Cohen, Kenneth S.

AU - Scadden, David T.

AU - Hartford, Alan C.

AU - Fischman, Alan J.

AU - Clark, Jeffrey W.

AU - Ryan, David P.

AU - Zhu, Andrew X.

AU - Blaszkowsky, Lawrence S.

AU - Chen, Helen X.

AU - Shellito, Paul C.

AU - Lauwers, Gregory Y.

AU - Jain, Rakesh K.

PY - 2004/6

Y1 - 2004/6

UR - http://www.scopus.com/inward/record.url?scp=2942738883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942738883&partnerID=8YFLogxK

U2 - 10.1038/nm0604-649c

DO - 10.1038/nm0604-649c

M3 - Comment/debate

AN - SCOPUS:2942738883

VL - 10

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 6

ER -